'Will help intensify fight': WHO welcomes India's Covid-19 vaccine approval
'The use of vaccine in prioritised populations, along with the continued implementation of other public health measures and community participation, will be important in reducing impact of Covid-19,' WHO South-East Asia wrote in a tweet
The World Health Organisation (WHO) has welcomed India's decision of giving emergency use authorisation to vaccines against the novel coronavirus, informed Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia on Sunday.
Earlier today, the Drugs Controller General of India (DCGI) granted permission to Serum Institue of India and Bharat Biotech's Covid-19 vaccines for "restricted use" in an emergency situation.
Addressing a media briefing today, VG Somani, DCGI has said, "After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situation and permission is being granted to M/s Cadila Healthcare for conduct of the Phase III clinical trial."
"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!